MARATTO

article · Scholars Journal of Applied Medical Sciences

Antisynthetase Syndrome with Anti-Jo-1 Antibodies Following Oxford-Astrazeneca COVID-19 Vaccination: Uncommon Case Report

2024Open accessMohammed V University

Abstract

Anti-synthetase syndrome (ASS) is an idiopathic inflammatory myopathy (IIM) with autoantibodies against one of many aminoacyl transfer RNA (tRNA) synthetases. Since the widespread introduction of the Sars-Cov 2 vaccines, a number of adverse reactions have been reported. In terms of these vaccines, Oxford AstraZeneca vaccines have been responsible for various side effects, but their benefits outweigh the risks. Cases of IIM following vaccination are rarely reported in the literature. Here we report a case of ASS in a patient who received the Oxford-Astrazeneca's Sars-Cov 2 vaccine.

Research topics

  • Inflammatory Myopathies and Dermatomyositis
  • Skin Diseases and Diabetes
  • Drug-Induced Adverse Reactions

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.36347/sjams.2024.v12i06.003

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.